An adsorption chromatography assay to probe bulk particle transport through hydrogels

Journal of Pharmaceutical Sciences

Volumn 101, Issue 1, 2012, Pages 436-442

  Vladescu, I ^a   Lieleg, O ^a   Jang, S ^a   Ribbeck, Katharina ^a  

^a Massachusetts Institute of Technology Cambridge   (United States)

Author keywords

Adsorption; Diffusion; Hydrogels; In vitro models; Mucosal delivery; Permeability

Indexed keywords

MUCIN; POLYMER;

ADSORPTION CHROMATOGRAPHY; CONTROLLED STUDY; DRUG DESIGN; DRUG SCREENING; HYDROGEL; NONHUMAN; NOTE; PERMEABILITY; PERMEABILITY BARRIER; PH;

EID: 82255174962     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22737     Document Type: Article

References (29)

1. Jones AR, Shusta EV. 2007. Blood-brain barrier transport of therapeutics via receptor-mediation. Pharm Res 24(9):1759-1771.
2. Bickel U, Yoshikawa T, Pardridge WM. 2001. Delivery of peptides and proteins through the blood-brain barrier. Adv Drug Deliv Rev 46(1-3):247-279.
3. Sinico C, Fadda AM. 2009. Vesicular carriers for dermal drug delivery. Expert Opin Drug Deliv 6(8):813-825.
4. Prausnitz MR, Langer R. 2008. Transdermal drug delivery. Nat Biotechnol 26(11):1261-1268.
5. Sanders N, De Smedt S, Demeester J. 2000. The physical properties of biogels and their permeability for macromolecular drugs and colloidal drug carriers. J Pharm Sci 89(7):835-849.
6. Sanders N, Rudolph C, Braeckmans K, De Smedt SC, Demeester J. 2009. Extracellular barriers in respiratory gene therapy. Adv Drug Deliv Rev 61(2):115-127.
7. Lieleg O, Ribbeck K. 2011. Biological hydrogels as selective diffusion barriers. Trends Cell Biol (Epub ahead of print).
8. Cone RA. 2009. Barrier properties of mucus. Adv Drug Deliv Rev 61(2):75-85.
9. Lai SK, Wang YY, Hanes J. 2008. Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. Adv Drug Deliv Rev 61(2):158-171.
10. Lieleg O, Baumgärtel RM, Bausch AR. 2009. Selective filtering of particles by the extracellular matrix: An electrostatic bandpass. Biophys J 97(6):1569-1577.
11. Caldorera-Moore M, Guimard N, Shi L, Roy KDesigner nanoparticles: Incorporating size, shape and triggered release into nanoscale drug carriers. Expert Opin Drug Deliv 7(4):479-495.
12. Huynh NT, Roger E, Lautram N, Benoit JP, Passirani C. 2010. The rise and rise of stealth nanocarriers for cancer therapy: Passive versus active targeting. Nanomedicine 5(9):1415-1433.
13. Celli J, Turner B, Afdhal N, Ewoldt R, McKinley G, Bansil R, Erramilli S. 2007. Rheology of gastric mucin exhibits a pH-dependent sol-gel transition. Biomacromolecules 8(5):1580-1586.
14. Green NM. 1990. Avidin and streptavidin. Method Enzymol 184:51-67.
15. Hoffman W, Jump A. 1989. Inhibition of the streptavidin-biotin interaction by milk. Anal Biochem 181(2):318-320.
16. Lai S, Wang Y, Wirtz D, Hanes J. 2009. Micro- and macrorheology of mucus. Adv Drug Deliv Rev 61(2):86-100.
17. Norris D, Sinko P. 1997. Effect of size, surface charge, and hydrophobicity on the translocation of polystyrene microspheres through gastrointestinal mucin. J Appl Polym Sci 63(11):1481-1492.
18. Broughton-Head V, Smith J, Shur J, Shute J. 2007. Actin limits enhancement of nanoparticle diffusion through cystic fibrosis sputum by mucolytics. Pulm Pharmacol Ther 20(6):708-717.
19. Lieleg O, Vladescu I, Ribbeck K. 2010. Characterization of particle translocation through mucin hydrogels. Biophys J 98(9):1782-1789.
20. Ovesen L, Bendtsen F, Tage-Jensen U, Pedersen N, Gram B, Rune S. 1986. Intraluminal pH in the stomach, duodenum, and proximal jejunum in normal subjects and patients with exocrine pancreatic insufficiency. Gastroenterology 90(4):958-962.
21. Karnad D, Mhaisekar D, Moralwar K. 1990. Respiratory mucus pH in tracheostomized intensive care unit patients: Effects of colonization and pneumonia. Crit Care Med 18(7):699-701.
22. Brunelli R, Papi M, Arcovito G, Bompiani A, Castagnola M, Parasassi T, Sampaolese B, Vincenzoni F, De Spirito M. 2007. Globular structure of human ovulatory cervical mucus. FASEB J 21(14):3872-3876.
23. Celli J, Turner B, Afdhal N, Keates S, Ghiran I, Kelly C, Ewoldt R, McKinley G, So P, Erramilli S, Bansil R. 2009. Helicobacter pylori moves through mucus by reducing mucin viscoelasticity. Proc Natl Acad Sci U S A 106(34):14321-14326.
24. Lai SK, Hida K, Shukair S, Wang YY, Figueiredo A, Cone R, Hope TJ, Hanes J. 2009. Human immunodeficiency virus type 1 is trapped by acidic but not by neutralized human cervicovaginal mucus. J Virol 83(21):11196-11200.
25. Tirouvanziam R, Conrad CK, Bottiglieri T, Herzenberg LA, Moss RB. 2006. High-dose oral N-acetylcysteine, a glutathione prodrug, modulates inflammation in cystic fibrosis. Proc Natl Acad Sci U S A 103(12):4628-4633.
26. Cu Y, Saltzman WM. 2009. Controlled surface modification with poly(ethylene)glycol enhances diffusion of PLGA nanoparticles in human cervical mucus. Mol Pharm 6(1):173-181.
27. Lai SK, O'Hanlon DE, Harrold S, Man ST, Wang YY, Cone R, Hanes J. 2007. Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus. Proc Natl Acad Sci U S A 104(5):1482-1487.
28. Suh J, Dawson M, Hanes J. 2005. Real-time multiple-particle tracking: Applications to drug and gene delivery. Adv Drug Deliv Rev 57(1):63-78.
29. Burruano B, Schnaare R, Malamud D. 2002. Synthetic cervical mucus formulation. Contraception 66(2):137-140.